查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1573089

COPD/气喘设备市场：按产品类型、应用、最终用户、分销管道分類的全球预测 - 2025-2030

COPD & Asthma Devices Market by Product Type (Accessories, Inhalers, Nebulizers), Application (Asthma, Chronic Obstructive Pulmonary Disease (COPD)), End-User, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年，慢性阻塞性肺病和气喘设备市场价值为353.3亿美元，预计2024年将达到374.5亿美元，复合年增长率为5.93%，到2030年将达到529亿美元。

慢性阻塞性肺病和气喘设备市场包括医疗设备和设计用于诊断、治疗和管理慢性阻塞性肺病（COPD）和气喘的设备。这包括吸入器、雾化器、氧气浓缩机、肺活量测定装置等，这些在临床和家庭环境中都是必不可少的。这些设备的需求源于由于污染、吸烟和人口老化等因素导致的呼吸道疾病的日益普及。这些设备对于有效给药、监测呼吸状态和改善患者生活品质至关重要。人们对呼吸系统健康的认识不断提高以及医疗技术的进步正在推动已开发市场和新兴市场的需求。关键的成长要素包括智慧吸入器和携带式雾化器等技术创新、医疗保健支出增加以及促进呼吸护理的政府支持政策。最新的机会在于数位医疗技术的集成，透过应用程式和物联网设备增强患者的依从性和监测。製造商可以利用这一点，投资研发，为精通科技的患者创造更容易使用、连结性更强的设备。然而，这个市场面临先进设备高成本、监管核准严格、低收入地区准入受限等挑战。此外，医疗保健基础设施的差异可能会阻碍新兴国家的市场成长。为了克服这些障碍，注重创新的公司应考虑具有成本效益的製造工艺，并寻求伙伴关係关係以扩大市场范围。此外，研究应旨在提高设备功效并减少副作用，以满足患者的特定需求。市场竞争仍然激烈，我们看到企业之间存在整合趋势，旨在透过併购扩大产品系列。总体而言，该行业不断发展，以患者为中心的数位创新有广阔的开拓，为慢性阻塞性肺病和气喘治疗设备市场提供了成长机会。

主要市场统计
基准年[2023] 353.3亿美元
预测年份 [2024] 374.5亿美元
预测年份 [2030] 529亿美元
复合年增长率（%） 5.93%

市场动态：针对快速发展的慢性阻塞性肺病和气喘设备市场所揭示的关键市场见解

供需的动态交互作用正在改变慢性阻塞性肺病和气喘设备市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 支持呼吸系统疾病管理和治疗的政府措施和政策
    • 新兴市场透过改善医疗服务为呼吸设备製造商提供了新的机会
    • 透过使用者友善的便携式设备设计提高患者对呼吸治疗的依从性
    • 环境污染加剧导致呼吸道疾病恶化，治疗设备的需求增加
  • 市场限制因素
    • 慢性阻塞性肺病和气喘设备製造缺乏标准化影响产品一致性
    • 医疗保健提供者在慢性阻塞性肺病和气喘治疗设备的最新进展方面面临的教育挑战
  • 市场机会
    • 慢性阻塞性肺病和气喘治疗方案中个人化医疗方法的兴起
    • 加强病患教育和自我管理计画以减少气喘住院率
    • 一种创新的药物传递系统，可提高慢性阻塞性肺病治疗的药物顺从性
  • 市场挑战
    • 确保患者坚持用药和遵守规定治疗方法的复杂性
    • 农村和服务欠缺地区的医疗服务有限

波特五力：驾驭慢性阻塞性肺病/气喘设备市场的策略工具

波特的五力是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解 COPD/气喘设备市场的外部影响

外部宏观环境因素在塑造慢性阻塞性肺病和气喘设备市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解慢性阻塞性肺病/气喘设备市场的竞争格局

对慢性阻塞性肺病和气喘设备市场的详细市场占有率分析提供了对供应商绩效的全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵 COPD 与气喘设备市场供应商的绩效评估

FPNV定位矩阵是评估COPD/气喘设备市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，描绘慢性阻塞性肺病和气喘设备市场的成功之路

对于旨在加强其全球市场影响力的公司来说，对慢性阻塞性肺病和气喘设备市场进行策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 支持呼吸系统疾病管理和治疗的政府措施和政策
      • 新兴市场透过增加医疗保健机会为呼吸系统製造商创造新机会
      • 易于使用的可携式设备设计提高了患者对呼吸治疗的依从性
      • 环境污染加剧导致呼吸道疾病恶化，增加对治疗设备的需求
    • 抑制因素
      • 慢性阻塞性肺病和气喘设备製造缺乏标准化影响产品一致性
      • 对医护人员进行有关慢性阻塞性肺病和气喘治疗设备最新进展的教育面临的挑战
    • 机会
      • 慢性阻塞性肺病和气喘治疗通讯协定中个人化医疗方法的兴起
      • 加强病患教育和自我管理计划，以减少与气喘相关的住院治疗
      • 创新的药物传递系统，可提高慢性阻塞性肺病治疗的用药依从性
    • 任务
      • 确保患者依从性和遵守规定治疗计画的併发症
      • 农村和服务欠缺地区获得医疗保健的机会有限
  • 市场区隔分析
  • 波特五力分析
  • PESTLE分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 COPD/气喘设备市场：依产品类型

  • 配件
    • 致动器
    • 干粉吸入器转子盖和药筒
    • 垫片
  • 吸入器
    • 干粉吸入器 (DPI)
    • 定量喷雾吸入器(MDI)
    • 缓雾吸入器
  • 喷雾器
    • 喷射雾化器
    • 网状雾化器
    • 超音波雾化器

第 7 章 COPD/气喘设备市场：依应用分类

  • 气喘
    • 过敏性气喘
    • 运动诱发的气喘
    • 非过敏性气喘
  • 慢性阻塞性肺病（COPD）
    • 慢性支气管炎
    • 气肿

第 8 章 COPD/气喘设备市场：依最终使用者分类

  • 门诊手术中心
  • 家庭护理设置
  • 医院/诊所
  • 专科诊所

第 9 章 COPD/气喘设备市场：依通路

  • 医院药房
  • 网路药房
  • 零售药房

第10章北美和南美的慢性阻塞性肺病/气喘设备市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区慢性阻塞性肺病/气喘设备市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的慢性阻塞性肺病/气喘设备市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议
Product Code: MRR-535C62918B2C

The COPD & Asthma Devices Market was valued at USD 35.33 billion in 2023, expected to reach USD 37.45 billion in 2024, and is projected to grow at a CAGR of 5.93%, to USD 52.90 billion by 2030.

The COPD and asthma devices market encompasses medical devices and equipment designed for the diagnosis, treatment, and management of Chronic Obstructive Pulmonary Disease (COPD) and asthma. This includes inhalers, nebulizers, oxygen concentrators, and spirometry devices, which are essential for clinical and home-based settings. The necessity of these devices stems from the increasing prevalence of respiratory diseases due to factors like pollution, smoking, and an aging population. These devices are pivotal in efficiently administering medications, monitoring respiratory conditions, and improving the quality of life for patients. The growing awareness about respiratory health and advancements in medical technology drive demand in both developed and developing markets. Key growth factors include technological innovations such as smart inhalers and portable nebulizers, increasing healthcare expenditure, and supportive government policies promoting respiratory care. Latest opportunities lie in the integration of digital health technologies, which offer enhanced patient adherence and monitoring through apps and IoT-enabled devices. Manufacturers can capitalize on this by investing in R&D to create more user-friendly and connected devices that cater to tech-savvy patients. However, the market faces challenges such as high costs of advanced devices, stringent regulatory approvals, and limited access in lower-income regions. Additionally, the disparity in healthcare infrastructure could hinder market growth in emerging economies. Companies focusing on innovation must consider cost-effective manufacturing processes and seek partnerships to expand market reach to overcome these barriers. Research should also target enhancing device effectiveness and reducing side effects to meet patient-specific needs. The market remains competitive, with consolidation trends as companies seek to expand their product portfolios through mergers and acquisitions. Overall, the industry continues evolving, with ample scope for development in patient-centered and digital innovations, which present lucrative opportunities for growth in the COPD and asthma devices market.

KEY MARKET STATISTICS
Base Year [2023] USD 35.33 billion
Estimated Year [2024] USD 37.45 billion
Forecast Year [2030] USD 52.90 billion
CAGR (%) 5.93%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving COPD & Asthma Devices Market

The COPD & Asthma Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Government initiatives and policies supporting respiratory disease management and treatment
    • Emerging markets creating new opportunities for respiratory device manufacturers through enhanced healthcare access
    • Improved patient adherence to respiratory therapies driven by user-friendly and portable device designs
    • Rising environmental pollution exacerbating respiratory conditions and increasing demand for treatment devices
  • Market Restraints
    • Lack of standardization in COPD & asthma device manufacturing affecting product consistency
    • Challenges in educating healthcare providers about the latest COPD & asthma device advancements
  • Market Opportunities
    • Rise of personalized medicine approaches in COPD and asthma treatment protocols
    • Growth in patient education and self-management programs to reduce asthma-related hospitalizations
    • Innovative drug delivery systems enhancing medication adherence in COPD treatments
  • Market Challenges
    • Complications in ensuring patient adherence and compliance with prescribed treatment regimens
    • Limited healthcare access in rural and underserved areas

Porter's Five Forces: A Strategic Tool for Navigating the COPD & Asthma Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the COPD & Asthma Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the COPD & Asthma Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the COPD & Asthma Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the COPD & Asthma Devices Market

A detailed market share analysis in the COPD & Asthma Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the COPD & Asthma Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the COPD & Asthma Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the COPD & Asthma Devices Market

A strategic analysis of the COPD & Asthma Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the COPD & Asthma Devices Market, highlighting leading vendors and their innovative profiles. These include 3M Health Care, Aerogen, Air Liquide Healthcare, Becton, Dickinson and Company, Chart Industries, Drive DeVilbiss Healthcare, Fisher & Paykel Healthcare, Getinge, GF Health Products, Inc., Hamilton Medical, Invacare Corporation, Koninklijke Philips N.V., Medtronic, Nihon Kohden Corporation, PARI Medical Holding, ResMed, Smiths Medical, SunMed, and Teleflex Incorporated.

Market Segmentation & Coverage

This research report categorizes the COPD & Asthma Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Accessories, Inhalers, and Nebulizers. The Accessories is further studied across Actuators, Dry Powder Inhaler Rotacaps & Cartridges, and Spacers. The Inhalers is further studied across Dry Powder Inhalers (DPI), Metered-Dose Inhalers (MDI), and Soft Mist Inhalers. The Nebulizers is further studied across Jet Nebulizers, Mesh Nebulizers, and Ultrasonic Nebulizers.
  • Based on Application, market is studied across Asthma and Chronic Obstructive Pulmonary Disease (COPD). The Asthma is further studied across Allergic Asthma, Exercise-Induced Asthma, and Non-Allergic Asthma. The Chronic Obstructive Pulmonary Disease (COPD) is further studied across Chronic Bronchitis and Emphysema.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Homecare Settings, Hospitals & Clinics, and Specialty Clinics.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Government initiatives and policies supporting respiratory disease management and treatment
      • 5.1.1.2. Emerging markets creating new opportunities for respiratory device manufacturers through enhanced healthcare access
      • 5.1.1.3. Improved patient adherence to respiratory therapies driven by user-friendly and portable device designs
      • 5.1.1.4. Rising environmental pollution exacerbating respiratory conditions and increasing demand for treatment devices
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of standardization in COPD & asthma device manufacturing affecting product consistency
      • 5.1.2.2. Challenges in educating healthcare providers about the latest COPD & asthma device advancements
    • 5.1.3. Opportunities
      • 5.1.3.1. Rise of personalized medicine approaches in COPD and asthma treatment protocols
      • 5.1.3.2. Growth in patient education and self-management programs to reduce asthma-related hospitalizations
      • 5.1.3.3. Innovative drug delivery systems enhancing medication adherence in COPD treatments
    • 5.1.4. Challenges
      • 5.1.4.1. Complications in ensuring patient adherence and compliance with prescribed treatment regimens
      • 5.1.4.2. Limited healthcare access in rural and underserved areas
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. COPD & Asthma Devices Market, by Product Type

  • 6.1. Introduction
  • 6.2. Accessories
    • 6.2.1. Actuators
    • 6.2.2. Dry Powder Inhaler Rotacaps & Cartridges
    • 6.2.3. Spacers
  • 6.3. Inhalers
    • 6.3.1. Dry Powder Inhalers (DPI)
    • 6.3.2. Metered-Dose Inhalers (MDI)
    • 6.3.3. Soft Mist Inhalers
  • 6.4. Nebulizers
    • 6.4.1. Jet Nebulizers
    • 6.4.2. Mesh Nebulizers
    • 6.4.3. Ultrasonic Nebulizers

7. COPD & Asthma Devices Market, by Application

  • 7.1. Introduction
  • 7.2. Asthma
    • 7.2.1. Allergic Asthma
    • 7.2.2. Exercise-Induced Asthma
    • 7.2.3. Non-Allergic Asthma
  • 7.3. Chronic Obstructive Pulmonary Disease (COPD)
    • 7.3.1. Chronic Bronchitis
    • 7.3.2. Emphysema

8. COPD & Asthma Devices Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Homecare Settings
  • 8.4. Hospitals & Clinics
  • 8.5. Specialty Clinics

9. COPD & Asthma Devices Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospital Pharmacies
  • 9.3. Online Pharmacies
  • 9.4. Retail Pharmacies

10. Americas COPD & Asthma Devices Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific COPD & Asthma Devices Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa COPD & Asthma Devices Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Health Care
  • 2. Aerogen
  • 3. Air Liquide Healthcare
  • 4. Becton, Dickinson and Company
  • 5. Chart Industries
  • 6. Drive DeVilbiss Healthcare
  • 7. Fisher & Paykel Healthcare
  • 8. Getinge
  • 9. GF Health Products, Inc.
  • 10. Hamilton Medical
  • 11. Invacare Corporation
  • 12. Koninklijke Philips N.V.
  • 13. Medtronic
  • 14. Nihon Kohden Corporation
  • 15. PARI Medical Holding
  • 16. ResMed
  • 17. Smiths Medical
  • 18. SunMed
  • 19. Teleflex Incorporated

LIST OF FIGURES

  • FIGURE 1. COPD & ASTHMA DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. COPD & ASTHMA DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. COPD & ASTHMA DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. COPD & ASTHMA DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. COPD & ASTHMA DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. COPD & ASTHMA DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY ACTUATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY DRY POWDER INHALER ROTACAPS & CARTRIDGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY SPACERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY DRY POWDER INHALERS (DPI), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY METERED-DOSE INHALERS (MDI), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY SOFT MIST INHALERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY JET NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY MESH NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY ALLERGIC ASTHMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY EXERCISE-INDUCED ASTHMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY NON-ALLERGIC ASTHMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC BRONCHITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY EMPHYSEMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 77. CANADA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. AUSTRALIA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. CHINA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 120. CHINA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 124. CHINA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. CHINA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. INDIA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. INDIA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 128. INDIA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 129. INDIA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 132. INDIA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 133. INDIA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. INDIA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 135. INDONESIA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. INDONESIA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 137. INDONESIA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 138. INDONESIA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. INDONESIA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 141. INDONESIA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 142. INDONESIA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. INDONESIA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. JAPAN COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. JAPAN COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 146. JAPAN COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 147. JAPAN COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 148. JAPAN COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. JAPAN COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 150. JAPAN COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 151. JAPAN COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. JAPAN COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 153. MALAYSIA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. MALAYSIA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 155. MALAYSIA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 156. MALAYSIA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 157. MALAYSIA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. MALAYSIA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 159. MALAYSIA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 160. MALAYSIA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. MALAYSIA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 162. PHILIPPINES COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. PHILIPPINES COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 164. PHILIPPINES COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 165. PHILIPPINES COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 166. PHILIPPINES COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. PHILIPPINES COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 168. PHILIPPINES COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 169. PHILIPPINES COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. PHILIPPINES COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 171. SINGAPORE COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SINGAPORE COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 173. SINGAPORE COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 174. SINGAPORE COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 175. SINGAPORE COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SINGAPORE COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 177. SINGAPORE COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 178. SINGAPORE COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. SINGAPORE COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 180. SOUTH KOREA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. SOUTH KOREA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 182. SOUTH KOREA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 183. SOUTH KOREA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 184. SOUTH KOREA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. SOUTH KOREA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 186. SOUTH KOREA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 187. SOUTH KOREA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. SOUTH KOREA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 189. TAIWAN COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. TAIWAN COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 191. TAIWAN COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 192. TAIWAN COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 193. TAIWAN COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. TAIWAN COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 195. TAIWAN COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 196. TAIWAN COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. TAIWAN COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 198. THAILAND COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. THAILAND COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 200. THAILAND COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 201. THAILAND COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 202. THAILAND COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. THAILAND COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 204. THAILAND COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 205. THAILAND COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. THAILAND COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 207. VIETNAM COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. VIETNAM COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 209. VIETNAM COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 210. VIETNAM COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 211. VIETNAM COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. VIETNAM COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 213. VIETNAM COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 214. VIETNAM COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. VIETNAM COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 226. DENMARK COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. DENMARK COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 228. DENMARK COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 229. DENMARK COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 230. DENMARK COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. DENMARK COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 232. DENMARK COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 233. DENMARK COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. DENMARK COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 235. EGYPT COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. EGYPT COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 237. EGYPT COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 238. EGYPT COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 239. EGYPT COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. EGYPT COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 241. EGYPT COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 242. EGYPT COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 243. EGYPT COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 244. FINLAND COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. FINLAND COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 246. FINLAND COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 247. FINLAND COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 248. FINLAND COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 249. FINLAND COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 250. FINLAND COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 251. FINLAND COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 252. FINLAND COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 253. FRANCE COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. FRANCE COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 255. FRANCE COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 256. FRANCE COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 257. FRANCE COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 258. FRANCE COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 259. FRANCE COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 260. FRANCE COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 261. FRANCE COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 262. GERMANY COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. GERMANY COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 264. GERMANY COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 265. GERMANY COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 266. GERMANY COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 267. GERMANY COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 268. GERMANY COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 269. GERMANY COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 270. GERMANY COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 271. ISRAEL COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 272. ISRAEL COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 273. ISRAEL COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 274. ISRAEL COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 275. ISRAEL COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 276. ISRAEL COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 277. ISRAEL COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 278. ISRAEL COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 279. ISRAEL COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 280. ITALY COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 281. ITALY COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 282. ITALY COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 283. ITALY COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 284. ITALY COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 285. ITALY COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 286. ITALY COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 287. ITALY COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 288. ITALY COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 289. NETHERLANDS COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 290. NETHERLANDS COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 291. NETHERLANDS COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 292. NETHERLANDS COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 293. NETHERLANDS COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 294. NETHERLANDS COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 295. NETHERLANDS COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 296. NETHERLANDS COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 297. NETHERLANDS COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 298. NIGERIA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 299. NIGERIA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 300. NIGERIA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 301. NIGERIA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 302. NIGERIA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 303. NIGERIA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 304. NIGERIA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 305. NIGERIA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 306. NIGERIA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 307. NORWAY COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 308. NORWAY COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 309. NORWAY COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 310. NORWAY COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 311. NORWAY COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 312. NORWAY COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 313. NORWAY COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 314. NORWAY COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 315. NORWAY COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 316. POLAND COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 317. POLAND COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 318. POLAND COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 319. POLAND COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 320. POLAND COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 321. POLAND COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 322. POLAND COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 323. POLAND COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 324. POLAND COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 325. QATAR COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 326. QATAR COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 327. QATAR COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 328. QATAR COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 329. QATAR COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 330. QATAR COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 331. QATAR COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 332. QATAR COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 333. QATAR COPD